Affinity Capital Advisors »

Esperion Therapeutics shares owned by Affinity Capital Advisors

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Affinity Capital Advisors from 13F filings

Historical chart of Affinity Capital Advisors investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Affinity Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Affinity Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $29k 10k 2.90
2025-06-30 $9.8k 10k 0.98
2025-03-31 $10k 10k 1.02

More positions owned by Affinity Capital Advisors

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core Total Usd (IUSB)
Vanguard Index Fds Value Etf (VTV)
Apple (AAPL)
Ishares Tr Eafe Value Etf (EFV)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Esg Awr Msci Usa (ESGU)
Select Sector Spdr Tr Technology (XLK)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Tr S&p 100 Etf (OEF)
Ishares Tr 10-20 Yr Trs Etf (TLH)
Ishares Tr Calif Mun Bd Etf (CMF)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)

View all positions for Affinity Capital Advisors

Top funds holding Esperion Therapeutics

BlackRock
Vanguard Group
Two Seas Capital
Daniel D. Thurber
PenderFund Capital Management
Geode Capital Management
State Street Corporation
Nuveen
AIGH Capital Management
Marshall Wace
Royce & Associates
Two Sigma Investments
Jane Street
Citadel Advisors
Two Sigma Advisers

View all funds holding Esperion Therapeutics